CD4 + CD25 + FoxP3 + T regulatory cells in subjects responsive or unresponsive to hepatitis B vaccination

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 11, 2011, Pages 1046-1051

  Li, Jincheng ^a,b   Tan, Deming ^a   Liu, Hongbo ^a   Li, Kecheng ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Shaoyang Medical College   (China)

^c Zhuhai Institute of Medical Genetics   (China)

Author keywords

Antigen; CD25; CD4; FoxP3; Hepatitis b vaccines; Immune response; T regulation cells

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GAMMA INTERFERON; HEPATITIS B VACCINE; INTERLEUKIN DERIVATIVE; MESSENGER RNA;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; CASE CONTROL STUDY; CYTOLOGY; FEMALE; GENETICS; HEPATITIS B; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; SECRETION (PROCESS); VACCINATION;

ADOLESCENT; ANTIBODY FORMATION; CASE-CONTROL STUDIES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MALE; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; VACCINATION; YOUNG ADULT;

EID: 84555196639     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.11.003     Document Type: Article

References (20)

1. Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China - declining HBV prevalence due to hepatitis B vaccination[J]. Vaccine,2009,27(47):6550-6557.
2. Shokri F, Jafarzadeh A. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates[J]. Vaccine, 2001, 19(31) :4544-4581.
3. Bauer T, Jilg W. Hepatitis B surface antigen-specifc T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination[J]. Vaccine,2006,24(5):572-577. (Pubitemid 43017822)
4. Sjogren M H. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination[ J]. Am J Med,2005,118 (suppl 10A): S34-S39.
5. + regulatory T cell of non-responders after hepatitis B surface antigen vaccine immunization [J]. Clin Immunol, 2008,129(1): 176-177.
6. + regulatory T cells in the blood of nonresponders after standard hepatitis B surface antigen vaccine immunization[ J]. Clin immunol, 2008,127(2); 265-266.
7. Schwonzen M, Diehl V, Dellanna M, et al. Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis [J]. Leuk Res, 2007, 31 (1):113-116. (Pubitemid 44709745)
8. Baratelli F, Lin Y, Zhu L, et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T Cells[J]. J Immunol, 2005, 175(3); 1483-1490. (Pubitemid 41023048)
9. + immunoregulatory cells [J]. J Immunol, 2001, 167(3): 1137-1140.
10. Woo E Y, Yeh H, Chu C S, et al. Cutting edge; regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation[J]. J Immunol,2002, 168(9) : 4272-4276. (Pubitemid 34441324)
11. + regulatory T cells [J]. J Immunol, 2005, 175(7): 4180-4183.
12. Lim H W, Hillsamer P, Kim C H. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses [J]. J Clin Invest, 2004, 114(11); 1640-1649. (Pubitemid 40385555)
13. Lingnau K, Hoehn P, Kerdine S, et al. IL-4 in combination with TGF-β favors an alternative pathway of ThI development independent of IL-12[J]. J Immunol, 1998, 161(9): 4709-4718. (Pubitemid 28492046)
14. Tsutsui H, Mizoguchi Y, Morisawa S. There is no correlation between function and lymphokine production of HBs-antigenspecific human CD4 (+) - cloned T cells [J]. Scand J Immunol, 1991, 34(4); 433-444.
15. + T-lymphocyte clones induced by vaccination with rHBsAg vaccine[J]. Gastroenterology, 1997, 112(6); 2017-2027.
16. Velu V, Sara vanan S, Nandakumar S, et al. Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines[J]. World J Gastroenterol, 2008, 14 (22) : 3534-3540.
17. Chedid M G, Deulofeut H, Yunis D E, et al. Defect in Th1like cells of nonresponders to hepatitis B vaccine[ J]. Hum Immunol, 1997, 58(1): 42-51. (Pubitemid 28027412)
18. Vingerhoets J, Vanham G, Kestens L, et al. Deficient T-cell responses in non-responders to hepatitis B vaccination : absence of THl cytokine production[ J]. Immunol Lett, 1994, 39(2) : 163-168. (Pubitemid 24131323)
19. Schlaak J F, Tully G, Löhr H F, et al. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines [J]. Clin Exp Immunol, 1999, 115(3): 508-514. (Pubitemid 29130368)
20. Evaluation of immunogenicity and safety of Genevac B : A new recombinant hepatitis b vaccine in comparison with Engerix B and Shanvac B in healthy adults[J]. Indian J Med Microbiol, 2004, 22 (1); 34-38.